The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Can combined chemo-radiation be started after induction chemotherapy in the curative treatment of stage III non-small cell lung carcinoma (NSCLC)? A multicenter, phase II study 5-year update.
S. Faria
No relevant relationships to disclose
S. P. Owen
No relevant relationships to disclose
D. Soulieres
No relevant relationships to disclose
P. Del Vecchio
No relevant relationships to disclose
L. Ofiara
No relevant relationships to disclose
J. M. Ayoub
Research Funding - Lilly; Wyeth
D. Charpentier
No relevant relationships to disclose
J. Gruber
No relevant relationships to disclose
J. F. Wan
No relevant relationships to disclose
L. Souhami
No relevant relationships to disclose
N. Kopek
No relevant relationships to disclose
V. Hirsh
Consultant or Advisory Role - Lilly